Waltham, MA 12/19/07; Fort Lauderdale, FL 12/19/07—PerkinElmer has definitively agreed to acquire Pediatrix Medical Group’s newborn metabolic screening business and its StepOne newborn screening product for cash. Pediatrix’s newborn screening laboratories provide neonatal screening and collaborative services to hospitals, medical groups, five states (Maryland, Mississippi, Louisiana, Nebraska, Pennsylvania) and the District of Columbia. The business is forecasted to post 2007 revenues of $15 million. StepOne can analyze more than 50 inherited disorders in newborns. “Adding laboratory capabilities should strengthen the partnership with our existing customers by enabling us to offer supplemental screening services for disorders beyond those currently mandated by state and federal governments,” commented PerkinElmer President and COO Robert F. Friel. “In addition, we would be able to provide our customers with supplemental support services, such as potential backup screening capabilities in the event of emergencies.” The acquisition is expected to close in the first quarter of 2008 and to be slightly accretive to PerkinElmer’s 2009 earnings.